DK151254C - Analogifremgangsmaade til fremstilling af 2-hydroxymethyl-pyrazin-derivater eller farmaceutisk acceptable salte deraf - Google Patents
Analogifremgangsmaade til fremstilling af 2-hydroxymethyl-pyrazin-derivater eller farmaceutisk acceptable salte derafInfo
- Publication number
- DK151254C DK151254C DK118879A DK118879A DK151254C DK 151254 C DK151254 C DK 151254C DK 118879 A DK118879 A DK 118879A DK 118879 A DK118879 A DK 118879A DK 151254 C DK151254 C DK 151254C
- Authority
- DK
- Denmark
- Prior art keywords
- hydroxymethyl
- analogue
- preparation
- acceptable salts
- pharmaceutical acceptable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/16—Halogen atoms; Nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/18—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/20—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2152078 | 1978-03-23 | ||
| IT21520/78A IT1094287B (it) | 1978-03-23 | 1978-03-23 | Derivati della 2-idrossimetil-pirazina aventi attivita' ipolipemizzante |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK118879A DK118879A (da) | 1979-09-24 |
| DK151254B DK151254B (da) | 1987-11-16 |
| DK151254C true DK151254C (da) | 1988-07-04 |
Family
ID=11183025
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK118879A DK151254C (da) | 1978-03-23 | 1979-03-22 | Analogifremgangsmaade til fremstilling af 2-hydroxymethyl-pyrazin-derivater eller farmaceutisk acceptable salte deraf |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US4267327A (de) |
| JP (1) | JPS5531063A (de) |
| BE (1) | BE875013A (de) |
| CA (1) | CA1146171A (de) |
| CH (1) | CH642639A5 (de) |
| DE (1) | DE2910824A1 (de) |
| DK (1) | DK151254C (de) |
| FR (2) | FR2448536A1 (de) |
| GB (1) | GB2017691B (de) |
| IT (1) | IT1094287B (de) |
| NL (1) | NL7902268A (de) |
| SE (1) | SE446338B (de) |
| ZA (1) | ZA791047B (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4406901A (en) * | 1980-02-06 | 1983-09-27 | Farmitalia Carlo Erba S.P.A. | Ethers of substituted hydroxymethylpyrazines |
| IL64267A (en) * | 1980-12-09 | 1985-08-30 | Erba Farmitalia | Ethers of hydroxymethylpyrazin-n-oxides,their preparation and pharmaceutical compositions containing them |
| JPS59219269A (ja) * | 1983-05-30 | 1984-12-10 | Terumo Corp | ピラジン誘導体を有効成分とする血小板凝集抑制剤 |
| DE3433960A1 (de) * | 1984-09-15 | 1986-03-27 | Basf Ag, 6700 Ludwigshafen | Verfahren zur herstellung von 2-amino-3-cyano-5-dialkoxymehtyl-pyrazinen und zwischenprodukte fuer diese verfahren |
| JPS63135216U (de) * | 1987-02-27 | 1988-09-05 | ||
| CN101684102B (zh) * | 2008-09-28 | 2013-06-05 | 安徽省新星药物开发有限责任公司 | 苯氧乙酸吡嗪酯类衍生物及其制法和用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4051245A (en) * | 1972-04-28 | 1977-09-27 | Carlo Erba, S.P.A. | Pyrazine 4-oxide derivatives and process for their preparation |
| GB1361967A (en) * | 1972-04-28 | 1974-07-30 | Erba Carlo Spa | Pyrazine 4-oxide derivatives and process for their preparation |
| US4002750A (en) * | 1972-04-28 | 1977-01-11 | Carlo Erba S.P.A. | Pyrazine 4-oxide derivatives and process for their preparation |
-
1978
- 1978-03-23 IT IT21520/78A patent/IT1094287B/it active
-
1979
- 1979-02-26 US US06/015,223 patent/US4267327A/en not_active Expired - Lifetime
- 1979-03-06 ZA ZA791047A patent/ZA791047B/xx unknown
- 1979-03-20 CH CH261779A patent/CH642639A5/de not_active IP Right Cessation
- 1979-03-20 DE DE19792910824 patent/DE2910824A1/de active Granted
- 1979-03-21 GB GB7909897A patent/GB2017691B/en not_active Expired
- 1979-03-22 NL NL7902268A patent/NL7902268A/xx not_active Application Discontinuation
- 1979-03-22 BE BE0/194146A patent/BE875013A/xx not_active IP Right Cessation
- 1979-03-22 DK DK118879A patent/DK151254C/da not_active IP Right Cessation
- 1979-03-22 CA CA000323983A patent/CA1146171A/en not_active Expired
- 1979-03-23 JP JP3340479A patent/JPS5531063A/ja active Granted
- 1979-03-23 SE SE7902661A patent/SE446338B/sv not_active IP Right Cessation
- 1979-03-23 FR FR7907433A patent/FR2448536A1/fr active Granted
-
1980
- 1980-02-27 FR FR8004355A patent/FR2445144A1/fr active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| FR2448536B1 (de) | 1983-01-28 |
| BE875013A (fr) | 1979-09-24 |
| DK118879A (da) | 1979-09-24 |
| IT7821520A0 (it) | 1978-03-23 |
| US4267327A (en) | 1981-05-12 |
| JPS6310697B2 (de) | 1988-03-08 |
| NL7902268A (nl) | 1979-09-25 |
| JPS5531063A (en) | 1980-03-05 |
| DE2910824C2 (de) | 1989-06-22 |
| FR2445144A1 (fr) | 1980-07-25 |
| GB2017691B (en) | 1982-06-16 |
| SE7902661L (sv) | 1979-09-24 |
| CA1146171A (en) | 1983-05-10 |
| IT1094287B (it) | 1985-07-26 |
| GB2017691A (en) | 1979-10-10 |
| ZA791047B (en) | 1980-03-26 |
| FR2448536A1 (fr) | 1980-09-05 |
| DE2910824A1 (de) | 1979-09-27 |
| SE446338B (sv) | 1986-09-01 |
| CH642639A5 (de) | 1984-04-30 |
| FR2445144B1 (de) | 1983-03-25 |
| DK151254B (da) | 1987-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK149449C (da) | Analogifremgangsmaade til fremstilling af carbostyrilderivater eller farmaceutisk acceptable salte deraf | |
| DK152495C (da) | Analogifremgangsmaade til fremstilling af n2-arylsulfonyl-l-argininamider eller farmaceutisk tolerable salte deraf | |
| DK161770C (da) | Analogifremgangsmaade til fremstilling af cyklobutylaminderivater eller farmaceutisk acceptable salte deraf | |
| DK145339C (da) | Analogifremgangsmaade til fremstilling af 4-amino-5-hexensyre eller farmaceutisk acceptable salte deraf | |
| DK163244C (da) | Analogifremgangsmaade til fremstilling af 7-oe2-(2-aminothiazol-4-yl)-2-oxyimino-acetamidoaa-ceph-3-em-4-carboxylsyrederivater eller fysiologisk acceptable salte deraf | |
| DK151623C (da) | Analogifremgangsmaade til fremstilling af n-substituerede moranolinderivater eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK164545C (da) | Analogifremgangsmaade til fremstilling af sulfonylamino- eller sulfonylaminoalkylphenoxyalkylcarbonsyrederivater eller fysiologisk uskadelige salte deraf | |
| DK160250C (da) | Analogifremgangsmaade til fremstilling af 4-substituerede piperidinoalkanon-derivater eller farmaceutisk acceptable salte deraf | |
| DK160940C (da) | Analogifremgangsmaade til fremstilling af benzoheterocycliske forbindelser eller farmaceutisk acceptable salte deraf | |
| DK152114C (da) | Analogifremgangsmaade til fremstilling af propenylaminer eller farmaceutisk acceptable salte deraf | |
| DK148477C (da) | Analogifremgangsmaade til fremstilling af tetrahydropyridinylindolderivater eller additionssalte deraf | |
| DK151330C (da) | Analogifremgangsmaade til fremstilling af aminoalkoholderivater eller farmaceutiske acceptable salte deraf | |
| DK161968C (da) | Analogifremgangsmaade til fremstilling af imidazo-pyrazolo-pyrimidiner eller farmaceutisk acceptable salte deraf | |
| DK158658C (da) | Analogifremgangsmaade til fremstilling af 9-aminoalkylfluorener eller farmaceutisk acceptable salte deraf | |
| DK155670C (da) | Analogifremgangsmaade til fremstilling af sesquiterpenderivater eller farmaceutisk acceptable salte deraf | |
| DK161699C (da) | Analogifremgangsmaade til fremstilling af 4-aryl-4-piperidincarbinoler eller farmaceutisk acceptable salte deraf | |
| DK149269C (da) | Analogifremgangsmaade til fremstilling af beta-mono- eller -difluormethyl-beta-alanin-derivater eller farmaceutisk acceptable salte eller optiske isomere deraf | |
| DK151805C (da) | Analogifremgangsmaade til fremstilling af 20,21-di-nor-eburnameninderivater eller farmaceutisk acceptable additionssalte deraf | |
| DK145263C (da) | Analogifremgangsmaade til fremstilling af imidazothiaziner eller farmaceutisk acceptable salte deraf | |
| DK149077C (da) | Analogifremgangsmaade til fremstilling af encephalin-analoge pentapeptidamidderivater eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK165005C (da) | Analogifremgangsmaade til fremstilling af 4,5-dihydro-4-oxofuran-2-carboxylsyrederivater eller terapeutisk acceptable salte deraf | |
| DK152208C (da) | Analogifremgangsmaade til fremstilling af 2-phenylamino-phenyleddikesyreamider eller farmaceutisk acceptable salte deraf | |
| DK143105C (da) | Analogifremgangsmaade til fremstilling af aminobenzocycloheptenderivater eller farmaceutisk acceptable additionssalte deraf | |
| DK162102C (da) | Analogifremgangsmaade til fremstilling af 3-o-(beta-d-glucoronopyranosyl)-sojasapogenol b eller farmaceutisk acceptable salte deraf | |
| DK149093C (da) | Analogifremgangsmaade til fremstilling af pentapeptidderivater eller farmaceutisk acceptable salte deraf |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PBP | Patent lapsed |